**Gene Editing Breakthrough: One-Time Therapy Cuts Cholesterol by 55%**
Gene Editing Therapy Slashes Cholesterol—Could Replace Statins In a landmark medical achievement, scientists have developed a gene-editing treatment that reduced cholesterol levels by 55% in a clinical trial. This innovative therapy, VERVE-101, targets the PCSK9…